Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camilla Evangelisti

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
British Journal of Clinical Pharmacology|March 9, 2016
Potential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria-related disordersCamilla Evangelisti, Vittoria Cenni, Giovanna Lattanzi
International Journal of Molecular Sciences|February 13, 2020
The Role Played by Wnt/β-Catenin Signaling Pathway in Acute Lymphoblastic LeukemiaFrancesca Chiarini, Francesca Paganelli, Alberto M Martelli, et al.
Trends in Pharmacological Sciences|December 16, 2014
Current treatment strategies for inhibiting mTOR in cancerFrancesca Chiarini, Camilla Evangelisti, James A McCubrey, et al.
International Journal of Molecular Sciences|June 29, 2018
Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An UpdateCamilla Evangelisti, Francesca Chiarini, James A McCubrey, et al.
Oncotarget|July 31, 2010
The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patientsAlberto M Martelli, Camilla Evangelisti, Francesca Chiarini, et al.
Biochimica Et Biophysica Acta|April 1, 2006
Nuclear protein kinase CAlberto M Martelli, Camilla Evangelisti, Maria Nyakern, et al.
Chemical Communications (Cambridge, England)|June 1, 2010
py(2)P(2)S(7): a bis(pyridine)adduct stabilized phosphorus sulfideChristiane Rotter, Camilla Evangelisti, Stefanie Schönberger, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|December 30, 2019
Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancerCamilla Evangelisti, Francesca Chiarini, Francesca Paganelli, et al.
Cancers|February 7, 2020
The Unfolded Protein Response: A Novel Therapeutic Target in Acute LeukemiasAlberto M Martelli, Francesca Paganelli, Francesca Chiarini, et al.
Leukemia|April 3, 2021
GSK-3: a multifaceted player in acute leukemiasAlberto M Martelli, Camilla Evangelisti, Francesca Paganelli, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
British Journal of Clinical Pharmacology|March 9, 2016
Potential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria-related disordersCamilla Evangelisti, Vittoria Cenni, Giovanna Lattanzi
International Journal of Molecular Sciences|February 13, 2020
The Role Played by Wnt/β-Catenin Signaling Pathway in Acute Lymphoblastic LeukemiaFrancesca Chiarini, Francesca Paganelli, Alberto M Martelli, et al.
Trends in Pharmacological Sciences|December 16, 2014
Current treatment strategies for inhibiting mTOR in cancerFrancesca Chiarini, Camilla Evangelisti, James A McCubrey, et al.
International Journal of Molecular Sciences|June 29, 2018
Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An UpdateCamilla Evangelisti, Francesca Chiarini, James A McCubrey, et al.
Oncotarget|July 31, 2010
The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patientsAlberto M Martelli, Camilla Evangelisti, Francesca Chiarini, et al.
Biochimica Et Biophysica Acta|April 1, 2006
Nuclear protein kinase CAlberto M Martelli, Camilla Evangelisti, Maria Nyakern, et al.
Chemical Communications (Cambridge, England)|June 1, 2010
py(2)P(2)S(7): a bis(pyridine)adduct stabilized phosphorus sulfideChristiane Rotter, Camilla Evangelisti, Stefanie Schönberger, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|December 30, 2019
Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancerCamilla Evangelisti, Francesca Chiarini, Francesca Paganelli, et al.
Cancers|February 7, 2020
The Unfolded Protein Response: A Novel Therapeutic Target in Acute LeukemiasAlberto M Martelli, Francesca Paganelli, Francesca Chiarini, et al.
Leukemia|April 3, 2021
GSK-3: a multifaceted player in acute leukemiasAlberto M Martelli, Camilla Evangelisti, Francesca Paganelli, et al.
Pageof 8